このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Nath Bio-Genes (India) 配当金
配当金 基準チェック /36
Nath Bio-Genes (India)配当を支払う会社であり、現在の利回りは0.88%で、収益によって十分にカバーされています。
主要情報
0.9%
配当利回り
10%
配当性向
| 業界平均利回り | 0.9% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | ₹2.000 |
| 一株当たり利益 | ₹20.94 |
| 配当利回り予想 | n/a |
最近の配当金アップデート
Recent updates
Here's Why Shareholders Should Examine Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) CEO Compensation Package More Closely
Aug 11
Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Solid Earnings May Rest On Weak Foundations
Jul 31Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Shares Fly 34% But Investors Aren't Buying For Growth
Jul 02These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Jun 27Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has More To Do To Multiply In Value Going Forward
Apr 05Returns On Capital At Nath Bio-Genes (India) (NSE:NATHBIOGEN) Have Hit The Brakes
Oct 24Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has Some Way To Go To Become A Multi-Bagger
Jun 07Some Investors May Be Worried About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Feb 11We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital Not Reflecting Well On The Business
Jun 19Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Returns On Capital Signal Tricky Times Ahead For Nath Bio-Genes (India) (NSE:NATHBIOGEN)
May 27Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28The Trends At Nath Bio-Genes (India) (NSE:NATHBIOGEN) That You Should Know About
Feb 07Declining Stock and Decent Financials: Is The Market Wrong About Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)?
Jan 19The Nath Bio-Genes (India) (NSE:NATHBIOGEN) Share Price Is Up 149% And Shareholders Are Boasting About It
Jan 01Why Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay Matters
Dec 14
These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Here's What To Make Of Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Nov 05Do Its Financials Have Any Role To Play In Driving Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) Stock Up Recently?
Oct 15Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Might Not Be As Mispriced As It Looks After Plunging 25%
Sep 24Many Still Looking Away From Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
Sep 08Introducing Nath Bio-Genes (India) (NSE:NATHBIOGEN), The Stock That Soared 311% In The Last Five Years
Sep 07Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Doing What It Can To Lift Shares
Aug 18Here's What We Think About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay
Jul 26Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) Likely To Turn Things Around?
Jul 09決済の安定と成長
配当データの取得
安定した配当: 配当金の支払いは安定していますが、 NATHBIOGENが配当金を支払っている期間は 10 年未満です。
増加する配当: NATHBIOGENは3年間のみ配当金を支払っており、それ以降支払額は増加していません。
配当利回り対市場
| Nath Bio-Genes (India) 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (NATHBIOGEN) | 0.9% |
| 市場下位25% (IN) | 0.2% |
| 市場トップ25% (IN) | 1.0% |
| 業界平均 (Food) | 0.9% |
| アナリスト予想 (NATHBIOGEN) (最長3年) | n/a |
注目すべき配当: NATHBIOGENの配当金 ( 0.99% ) はIndian市場の配当金支払者の下位 25% ( 0.27% ) よりも高くなっています。
高配当: NATHBIOGENの配当金 ( 0.99% ) はIndian市場の配当金支払者の上位 25% ( 1.16% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: NATHBIOGENの配当性向は低く ( 10.3% )、配当金は利益によって十分にカバーされています。
株主配当金
キャッシュフローカバレッジ: NATHBIOGENは 現金配当性向 ( 8.7% ) が低いため、配当金の支払いはキャッシュフローによって完全にカバーされています。